The US is "looking at options" to ship millions of AstraZeneca vaccines to India but that can happen only after it clears federal safety review, the White House said on Monday. This process could take a few "weeks".

Approximately 10 million doses "could be released if and when FDA gets gives us concurrence, which could happen in the coming weeks", a senior Biden administration official told reporters at a briefing, where IANS was present.